• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与一个基于大规模艾滋病毒人群队列相关的死亡率、死因及相关因素

Mortality, Causes of Death and Associated Factors Relate to a Large HIV Population-Based Cohort.

作者信息

Garriga César, García de Olalla Patricia, Miró Josep M, Ocaña Inma, Knobel Hernando, Barberá Maria Jesús, Humet Victoria, Domingo Pere, Gatell Josep M, Ribera Esteve, Gurguí Mercè, Marco Andrés, Caylà Joan A

机构信息

Epidemiology Service, Public Health Agency of Barcelona, Barcelona, Spain.

Spanish Field Epidemiology Training Programme, National Centre for Epidemiology, Instituto de Salud Carlos III, Madrid, Spain.

出版信息

PLoS One. 2015 Dec 30;10(12):e0145701. doi: 10.1371/journal.pone.0145701. eCollection 2015.

DOI:10.1371/journal.pone.0145701
PMID:26716982
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4696823/
Abstract

INTRODUCTION

Antiretroviral therapy has led to a decrease in HIV-related mortality and to the emergence of non-AIDS defining diseases as competing causes of death. This study estimates the HIV mortality rate and their risk factors with regard to different causes in a large city from January 2001 to June 2013.

MATERIALS AND METHODS

We followed-up 3137 newly diagnosed HIV non-AIDS cases. Causes of death were classified as HIV-related, non-HIV-related and external. We examined the effect of risk factors on survival using mortality rates, Kaplan-Meier plots and Cox models. Finally, we estimated survival for each main cause of death groups through Fine and Gray models.

MORTALITY RESULTS

182 deaths were found [14.0/1000 person-years of follow-up (py); 95% confidence interval (CI):12.0-16.1/1000 py], 81.3% of them had a known cause of death. Mortality rate by HIV-related causes and non-HIV-related causes was the same (4.9/1000 py; CI:3.7-6.1/1000 py), external was lower [1.7/1000 py; (1.0-2.4/1000 py)].

SURVIVAL RESULTS

Kaplan-Meier estimate showed worse survival in intravenous drug user (IDU) and heterosexuals than in men having sex with men (MSM). Factors associated with HIV-related causes of death include: IDU male (subHazard Ratio (sHR):3.2; CI:1.5-7.0) and <200 CD4 at diagnosis (sHR:2.7; CI:1.3-5.7) versus ≥500 CD4. Factors associated with non-HIV-related causes of death include: ageing (sHR:1.5; CI:1.4-1.7) and heterosexual female (sHR:2.8; CI:1.1-7.3) versus MSM. Factors associated with external causes of death were IDU male (sHR:28.7; CI:6.7-123.2) and heterosexual male (sHR:11.8; CI:2.5-56.4) versus MSM.

CONCLUSION AND RECOMMENDATION

There are important differences in survival among transmission groups. Improved treatment is especially necessary in IDUs and heterosexual males.

摘要

引言

抗逆转录病毒疗法已使与艾滋病相关的死亡率有所下降,并且出现了非艾滋病定义疾病成为相互竞争的死亡原因。本研究估计了2001年1月至2013年6月期间一个大城市中不同病因的艾滋病死亡率及其危险因素。

材料与方法

我们对3137例新诊断的艾滋病非艾滋病病例进行了随访。死亡原因分为与艾滋病相关、与艾滋病无关和外部原因。我们使用死亡率、Kaplan-Meier曲线和Cox模型研究了危险因素对生存的影响。最后,我们通过Fine和Gray模型估计了每个主要死亡原因组的生存率。

死亡率结果

共发现182例死亡[14.0/1000人年随访(py);95%置信区间(CI):12.0 - 16.1/1000 py],其中81.3%有已知的死亡原因。与艾滋病相关原因和与艾滋病无关原因的死亡率相同(4.9/1000 py;CI:3.7 - 6.1/1000 py),外部原因较低[1.7/1000 py;(1.0 - 2.4/1000 py)]。

生存结果

Kaplan-Meier估计显示,静脉吸毒者(IDU)和异性恋者的生存率低于男男性行为者(MSM)。与艾滋病相关死亡原因相关的因素包括:IDU男性(亚危险比(sHR):3.2;CI:1.5 - 7.0)以及诊断时CD4<200(sHR:2.7;CI:1.3 - 5.7)与CD4≥500相比。与艾滋病无关死亡原因相关的因素包括:年龄增长(sHR:1.5;CI:1.4 - 1.7)以及异性恋女性(sHR:2.8;CI:1.1 - 7.3)与MSM相比。与外部原因死亡相关的因素是IDU男性(sHR:28.7;CI:6.7 - 123.2)和异性恋男性(sHR:1`1.8;CI:2.5 - 56.4)与MSM相比。

结论与建议

不同传播组之间的生存率存在重要差异。对IDU和异性恋男性尤其需要改善治疗。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b030/4696823/ed6083d3d15f/pone.0145701.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b030/4696823/ed6083d3d15f/pone.0145701.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b030/4696823/ed6083d3d15f/pone.0145701.g001.jpg

相似文献

1
Mortality, Causes of Death and Associated Factors Relate to a Large HIV Population-Based Cohort.与一个基于大规模艾滋病毒人群队列相关的死亡率、死因及相关因素
PLoS One. 2015 Dec 30;10(12):e0145701. doi: 10.1371/journal.pone.0145701. eCollection 2015.
2
Mortality in HIV-infected women, heterosexual men, and men who have sex with men in Rio de Janeiro, Brazil: an observational cohort study.巴西里约热内卢感染艾滋病毒的女性、异性恋男性和男男性接触者的死亡率:一项观察性队列研究。
Lancet HIV. 2016 Oct;3(10):e490-8. doi: 10.1016/S2352-3018(16)30052-2. Epub 2016 Aug 17.
3
The effect of injecting drug use history on disease progression and death among HIV-positive individuals initiating combination antiretroviral therapy: collaborative cohort analysis.注射吸毒史对开始联合抗逆转录病毒治疗的 HIV 阳性个体疾病进展和死亡的影响:合作队列分析。
HIV Med. 2012 Feb;13(2):89-97. doi: 10.1111/j.1468-1293.2011.00940.x. Epub 2011 Aug 7.
4
[AIDS and injecting drug use: survival determinants in the highly active antiretroviral therapy era].[艾滋病与注射吸毒:高效抗逆转录病毒治疗时代的生存决定因素]
Epidemiol Prev. 2009 Jul-Oct;33(4-5):184-9.
5
Mortality of HIV-infected patients starting potent antiretroviral therapy: comparison with the general population in nine industrialized countries.感染 HIV 的患者开始接受高效抗逆转录病毒治疗后的死亡率:与九个工业化国家普通人群的比较。
Int J Epidemiol. 2009 Dec;38(6):1624-33. doi: 10.1093/ije/dyp306. Epub 2009 Oct 9.
6
Influence of noninjecting and injecting drug use on mortality, retention in the cohort, and antiretroviral therapy, in participants in the Swiss HIV Cohort Study.瑞士HIV队列研究参与者中,非注射吸毒和注射吸毒对死亡率、队列留存率及抗逆转录病毒治疗的影响。
HIV Med. 2015 Mar;16(3):137-51. doi: 10.1111/hiv.12184. Epub 2014 Aug 15.
7
[Trends in mortality and causes of death among persons with HIV infection, 1985-2004].[1985 - 2004年艾滋病毒感染者的死亡率及死亡原因趋势]
Enferm Infecc Microbiol Clin. 2007 Jan;25(1):5-10. doi: 10.1157/13096746.
8
A comparison of exposure groups in the EuroSIDA study: starting highly active antiretroviral therapy (HAART), response to HAART, and survival.欧洲艾滋病临床研究(EuroSIDA)中暴露组的比较:开始高效抗逆转录病毒治疗(HAART)、对HAART的反应及生存情况。
J Acquir Immune Defic Syndr. 1999 Dec 1;22(4):369-78. doi: 10.1097/00126334-199912010-00008.
9
Incidence, risk factors and causes of death in an HIV care programme with a large proportion of injecting drug users.在一个有大量注射吸毒者的艾滋病毒护理项目中,发病率、风险因素和死亡原因。
Trop Med Int Health. 2012 Oct;17(10):1255-63. doi: 10.1111/j.1365-3156.2012.03056.x. Epub 2012 Aug 5.
10
Gender differences in progression to AIDS and death from HIV seroconversion in a cohort of injecting drug users from 1986 to 2001.1986年至2001年一组注射吸毒者中从HIV血清转化发展为艾滋病及死亡的性别差异。
J Epidemiol Community Health. 2004 Nov;58(11):944-50. doi: 10.1136/jech.2003.017475.

引用本文的文献

1
Sustainment and adaptation of systems navigation and psychosocial counseling across HIV testing clinics in Vietnam: A qualitative assessment.越南各艾滋病毒检测诊所系统导航与心理社会咨询的维持与适应:一项定性评估。
Implement Res Pract. 2025 Feb 18;6:26334895251319812. doi: 10.1177/26334895251319812. eCollection 2025 Jan-Dec.
2
Construction and validation of a nomogram to predict 1-year mortality risk in patients with HIV/AIDS undergoing maintenance hemodialysis.构建并验证用于预测接受维持性血液透析的HIV/AIDS患者1年死亡风险的列线图。
Ren Fail. 2025 Dec;47(1):2461665. doi: 10.1080/0886022X.2025.2461665. Epub 2025 Feb 17.
3

本文引用的文献

1
Changes in HIV RNA and CD4 cell count after acute HCV infection in chronically HIV-infected individuals.慢性HIV感染者急性HCV感染后HIV RNA和CD4细胞计数的变化。
J Acquir Immune Defic Syndr. 2015 Apr 15;68(5):536-42. doi: 10.1097/QAI.0000000000000514.
2
Hepatitis B and human immunodeficiency virus co-infection.乙型肝炎与人类免疫缺陷病毒合并感染。
World J Gastroenterol. 2014 Dec 14;20(46):17360-7. doi: 10.3748/wjg.v20.i46.17360.
3
Late diagnosis among our ageing HIV population: a cohort study.我国老年艾滋病毒感染者的延迟诊断:一项队列研究。
Sex stratification of the trends and risk of mortality among individuals living with HIV under different transmission categories.
HIV 感染者在不同传播途径下的死亡率趋势及其风险的性别分层。
Sci Rep. 2022 Jun 3;12(1):9266. doi: 10.1038/s41598-022-13294-y.
4
A comparative analysis on characteristics and mortalities of four key transmission populations on antiretroviral therapy: a retrospective cohort study in Northwest China.在中国西北地区,对接受抗逆转录病毒治疗的 4 种关键传播人群的特征和死亡率进行了对比分析:一项回顾性队列研究。
BMC Infect Dis. 2022 Mar 28;22(1):299. doi: 10.1186/s12879-022-07281-x.
5
Epidemiologic and Economic Analysis of Rapid Antiretroviral Therapy Initiation with Bictegravir/Emtricitabine/Tenofovir Alafenamide in Spain.西班牙使用比克替拉韦/恩曲他滨/替诺福韦艾拉酚胺快速启动抗逆转录病毒治疗的流行病学和经济学分析
Pharmacoecon Open. 2022 May;6(3):415-424. doi: 10.1007/s41669-022-00322-w. Epub 2022 Feb 5.
6
Causes of death and associated factors over a decade of follow-up in a cohort of people living with HIV in rural Tanzania.在坦桑尼亚农村的一个艾滋病毒感染者队列中,经过十多年的随访,其死亡原因和相关因素。
BMC Infect Dis. 2022 Jan 6;22(1):37. doi: 10.1186/s12879-021-06962-3.
7
Identifying risk factors for late HIV diagnosis and survival analysis of people living with HIV/AIDS in Iran (1987-2016).伊朗艾滋病毒感染者(1987-2016 年)的晚期 HIV 诊断风险因素识别和生存分析。
BMC Infect Dis. 2021 Apr 27;21(1):390. doi: 10.1186/s12879-021-06100-z.
8
Trends of Cause of Death among Human Immunodeficiency Virus Patients and the Impact of Low CD4 Counts on Diagnosis to Death: a Retrospective Cohort Study.人类免疫缺陷病毒患者死因趋势及低 CD4 计数对诊断至死亡的影响:一项回顾性队列研究。
J Korean Med Sci. 2020 Oct 26;35(41):e355. doi: 10.3346/jkms.2020.35.e355.
9
Effects of HIV-1 genotype on baseline CD4+ cell count and mortality before and after antiretroviral therapy.HIV-1 基因型对接受抗逆转录病毒治疗前后基线 CD4+ 细胞计数和死亡率的影响。
Sci Rep. 2020 Sep 28;10(1):15875. doi: 10.1038/s41598-020-72701-4.
10
Trends and causes of mortality in a population-based cohort of HIV-infected adults in Spain: comparison with the general population.基于人群的西班牙 HIV 感染成年人队列的死亡率趋势和原因:与普通人群的比较。
Sci Rep. 2020 Jun 2;10(1):8922. doi: 10.1038/s41598-020-65841-0.
J Int AIDS Soc. 2014 Nov 2;17(4 Suppl 3):19692. doi: 10.7448/IAS.17.4.19692. eCollection 2014.
4
Predictors and correlates of adherence to combination antiretroviral therapy (ART) for chronic HIV infection: a meta-analysis.慢性HIV感染患者联合抗逆转录病毒疗法(ART)依从性的预测因素及相关因素:一项荟萃分析。
BMC Med. 2014 Aug 21;12:142. doi: 10.1186/PREACCEPT-1453408941291432.
5
A low-cost, sustainable, second generation system for surveillance of people living with HIV in Spain: 10-year trends in behavioural and clinical indicators, 2002 to 2011.西班牙针对艾滋病毒感染者的低成本、可持续的第二代监测系统:2002 年至 2011 年行为和临床指标的 10 年趋势。
Euro Surveill. 2014 May 22;19(20):20805. doi: 10.2807/1560-7917.es2014.19.20.20805.
6
Biomarkers of inflammation, coagulation and microbial translocation in HIV/HCV co-infected patients in the SMART study.在 SMART 研究中,HIV/HCV 合并感染患者的炎症、凝血和微生物易位的生物标志物。
J Clin Virol. 2014 Jul;60(3):295-300. doi: 10.1016/j.jcv.2014.03.017. Epub 2014 Apr 8.
7
Employment status in persons with and without HIV infection in Denmark: 1996-2011.丹麦1996年至2011年期间感染和未感染艾滋病毒人群的就业状况。
AIDS. 2014 Jun 19;28(10):1489-98. doi: 10.1097/QAD.0000000000000257.
8
Adjudicated morbidity and mortality outcomes by age among individuals with HIV infection on suppressive antiretroviral therapy.接受抑制性抗逆转录病毒治疗的HIV感染者按年龄划分的已判定发病和死亡结局。
PLoS One. 2014 Apr 11;9(4):e95061. doi: 10.1371/journal.pone.0095061. eCollection 2014.
9
Revised surveillance case definition for HIV infection--United States, 2014.修订后的 HIV 感染监测病例定义——美国,2014 年。
MMWR Recomm Rep. 2014 Apr 11;63(RR-03):1-10.
10
Educational attainment and risk of HIV infection, response to antiretroviral treatment, and mortality in HIV-infected patients.教育程度与HIV感染风险、对抗逆转录病毒治疗的反应以及HIV感染患者的死亡率
AIDS. 2014 Jan 28;28(3):387-96. doi: 10.1097/QAD.0000000000000032.